Metastatic breast cancer prognosis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Neoplastic Cells, Circulating Tumor Cells, Cultured MCF-7 Cells Axilla Neoplastic Stem Cells Lymph Nodes Mammary Glands, Human Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases45

Breast Neoplasms Neoplasm Metastasis Lymphatic Metastasis Neoplasm Recurrence, Local Carcinoma, Ductal, Breast Disease Progression Bone Neoplasms Neoplasm Invasiveness Neoplastic Cells, Circulating Lung Neoplasms Breast Neoplasms, Male Carcinoma Carcinoma, Lobular Neoplasms Breast Diseases Mammary Neoplasms, Experimental Adenocarcinoma Neutropenia Neoplasms, Hormone-Dependent Ovarian Neoplasms Liver Neoplasms Prostatic Neoplasms Carcinoma, Intraductal, Noninfiltrating Hematologic Diseases Carcinoma, Ductal Inflammatory Breast Neoplasms Genetic Predisposition to Disease Colorectal Neoplasms Alopecia Soft Tissue Neoplasms Colonic Neoplasms Brain Neoplasms Mammary Neoplasms, Animal Nausea Fibrocystic Breast Disease Fatigue Leukopenia Stomach Neoplasms Neovascularization, Pathologic Cell Transformation, Neoplastic Hand-Foot Syndrome Recurrence Osteolysis Carcinoma in Situ Peripheral Nervous System Diseases

Chemicals and Drugs76

Receptor, erbB-2 Tumor Markers, Biological Receptors, Estrogen Receptors, Progesterone Taxoids Paclitaxel Anthracyclines Antibodies, Monoclonal, Humanized Antineoplastic Agents Tamoxifen Fluorouracil Cyclophosphamide Bridged Compounds Epirubicin Deoxycytidine Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic Doxorubicin Vinblastine Antibodies, Monoclonal Fluoxymesterone Thiotepa Aromatase Inhibitors Epothilones Antibiotics, Antineoplastic Neoplasm Proteins Nitriles Quinazolines Estrogen Antagonists Maytansine Mucin-1 Mitolactol Triazoles Antimetabolites, Antineoplastic Mitoxantrone Fadrozole Receptor, Fibroblast Growth Factor, Type 4 Megestrol Acetate Estrogen Receptor Modulators Aminoglutethimide Megestrol Estrogens Estrogen Receptor alpha Methotrexate Estradiol RNA, Messenger Granulocyte Colony-Stimulating Factor Toremifene DNA, Neoplasm Selective Estrogen Receptor Modulators Antigens, Neoplasm Receptor, Epidermal Growth Factor RNA, Small Interfering Ketones Carboplatin Furans BRCA2 Protein Ki-67 Antigen Carcinoembryonic Antigen Cisplatin BRCA1 Protein Protein Kinase Inhibitors Diphosphonates Tumor Suppressor Protein p53 Mammaglobin A Cancer Vaccines Antigens, Tumor-Associated, Carbohydrate Goserelin MicroRNAs Leucovorin Prodrugs Melphalan RNA, Neoplasm Tumor Suppressor Proteins Angiogenesis Inhibitors Vascular Endothelial Growth Factor A

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Prognosis Survival Analysis Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Survival Rate Gene Expression Profiling Treatment Outcome Drug Administration Schedule Follow-Up Studies Proportional Hazards Models Prospective Studies Cohort Studies Kaplan-Meier Estimate Retrospective Studies Immunohistochemistry Chemotherapy, Adjuvant Infusions, Intravenous Risk Factors Mammary Neoplasms, Experimental Combined Modality Therapy Predictive Value of Tests Mammography Mastectomy Clinical Trials as Topic Multivariate Analysis Oligonucleotide Array Sequence Analysis Reverse Transcriptase Polymerase Chain Reaction Tissue Array Analysis Case-Control Studies Clinical Trials, Phase III as Topic Administration, Oral Early Detection of Cancer In Situ Hybridization, Fluorescence Salvage Therapy Risk Assessment Sensitivity and Specificity Tumor Burden Neoplasm Transplantation Xenograft Model Antitumor Assays Drug Evaluation Clinical Trials, Phase II as Topic Randomized Controlled Trials as Topic Maximum Tolerated Dose Molecular Targeted Therapy Risk Remission Induction Breast Self-Examination Blotting, Western Transplantation, Heterologous Hematopoietic Stem Cell Transplantation Neoadjuvant Therapy Feasibility Studies Confidence Intervals Incidence Transplantation, Autologous Immunoenzyme Techniques Pilot Projects Palliative Care Odds Ratio Logistic Models Reproducibility of Results Mastectomy, Segmental Biopsy, Needle Transfection ROC Curve Registries Polymerase Chain Reaction Questionnaires Models, Statistical Drug Screening Assays, Antitumor Probability Neoplasm Grading Ultrasonography, Mammary Treatment Failure Drug Delivery Systems SEER Program Positron-Emission Tomography

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes43

Gene Expression Regulation, Neoplastic Genes, erbB-2 Drug Resistance, Neoplasm Postmenopause Time Factors Dose-Response Relationship, Drug Menopause Premenopause Cell Proliferation Genes, BRCA1 Gene Amplification Sensitivity and Specificity Cell Movement Genetic Predisposition to Disease Signal Transduction Breast Feeding Genotype Maximum Tolerated Dose Apoptosis Risk Mutation Genes, BRCA2 Algorithms Odds Ratio Cell Division Polymorphism, Single Nucleotide Up-Regulation Transfection Cell Growth Processes Drug Synergism Down-Regulation RNA Interference Epithelial-Mesenchymal Transition Tumor Microenvironment Promoter Regions, Genetic Cell Survival Probability Gene Expression Gene Silencing Osteolysis Germ-Line Mutation Phenotype DNA Methylation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Humanities1

Quality of Life

Information Science6

Survival Rate Incidence Algorithms Registries Questionnaires SEER Program

Named Groups1

Health Care37

Survival Analysis Disease-Free Survival Survival Rate Treatment Outcome Follow-Up Studies Proportional Hazards Models Prospective Studies Cohort Studies Kaplan-Meier Estimate Retrospective Studies Risk Factors Predictive Value of Tests Clinical Trials as Topic Multivariate Analysis Case-Control Studies Clinical Trials, Phase III as Topic Risk Assessment Sensitivity and Specificity Age Factors Clinical Trials, Phase II as Topic Randomized Controlled Trials as Topic Risk Feasibility Studies Confidence Intervals Incidence Pilot Projects Palliative Care Odds Ratio Logistic Models Reproducibility of Results ROC Curve Registries Questionnaires Models, Statistical Probability Treatment Failure SEER Program

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Neoplasms Prognosis Neoplasm Metastasis Receptor, erbB-2 Tumor Markers, Biological Receptors, Estrogen Survival Analysis Breast Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Receptors, Progesterone Taxoids Survival Rate Paclitaxel Anthracyclines Gene Expression Profiling Antibodies, Monoclonal, Humanized Lymphatic Metastasis Treatment Outcome Survivors Neoplasm Recurrence, Local Antineoplastic Agents Carcinoma, Ductal, Breast Drug Administration Schedule Cell Line, Tumor Tamoxifen Fluorouracil Disease Progression Gene Expression Regulation, Neoplastic Follow-Up Studies Bone Neoplasms Cyclophosphamide Bridged Compounds Epirubicin Proportional Hazards Models Deoxycytidine Neoplasm Invasiveness Antineoplastic Agents, Hormonal Prospective Studies Antineoplastic Agents, Phytogenic Cohort Studies Neoplastic Cells, Circulating Doxorubicin Genes, erbB-2 Vinblastine Drug Resistance, Neoplasm Antibodies, Monoclonal Kaplan-Meier Estimate Fluoxymesterone Lung Neoplasms Breast Neoplasms, Male Carcinoma Thiotepa Aromatase Inhibitors Epothilones Retrospective Studies Immunohistochemistry Carcinoma, Lobular Antibiotics, Antineoplastic Chemotherapy, Adjuvant Postmenopause Time Factors Infusions, Intravenous Risk Factors Neoplasms Breast Diseases Neoplasm Proteins Nitriles Mammary Neoplasms, Experimental Combined Modality Therapy Adenocarcinoma Neutropenia Predictive Value of Tests Dose-Response Relationship, Drug Quinazolines Mammography Mastectomy Estrogen Antagonists Maytansine Clinical Trials as Topic Neoplasms, Hormone-Dependent Multivariate Analysis Mucin-1 Mitolactol Oligonucleotide Array Sequence Analysis Triazoles Reverse Transcriptase Polymerase Chain Reaction Antimetabolites, Antineoplastic Menopause Mice, Nude Ovarian Neoplasms Tissue Array Analysis Case-Control Studies Clinical Trials, Phase III as Topic Mitoxantrone Tumor Cells, Cultured Fadrozole Administration, Oral Receptor, Fibroblast Growth Factor, Type 4

No FAQ available that match "metastatic breast cancer prognosis"